KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Assets (2016 - 2025)

Historic Assets for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to $66.0 million.

  • LifeMD's Assets fell 906.36% to $66.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.0 million, marking a year-over-year decrease of 906.36%. This contributed to the annual value of $76.1 million for FY2024, which is 3012.2% up from last year.
  • Per LifeMD's latest filing, its Assets stood at $66.0 million for Q3 2025, which was down 906.36% from $73.6 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Assets ranged from a high of $76.1 million in Q4 2024 and a low of $16.4 million during Q3 2021
  • Its 5-year average for Assets is $46.7 million, with a median of $40.7 million in 2023.
  • Its Assets has fluctuated over the past 5 years, first skyrocketed by 71812.78% in 2021, then plummeted by 4858.94% in 2022.
  • Quarter analysis of 5 years shows LifeMD's Assets stood at $49.9 million in 2021, then crashed by 48.59% to $25.7 million in 2022, then skyrocketed by 127.85% to $58.5 million in 2023, then skyrocketed by 30.12% to $76.1 million in 2024, then fell by 13.29% to $66.0 million in 2025.
  • Its Assets was $66.0 million in Q3 2025, compared to $73.6 million in Q2 2025 and $73.6 million in Q1 2025.